Abstract

BackgroundRobot-assisted surgery is increasingly implemented for the resection of colorectal cancer, although the scientific evidence for adopting this technique is still limited. This study’s main objective was to compare short-term complication rates, oncological outcomes, and the inflammatory stress response after colorectal resection for cancer performed laparoscopic or robot-assisted.MethodsWe conducted a retrospective cohort study comparing the robot-assisted approach to laparoscopic surgery for elective malignant colorectal neoplasm. Certified colorectal and da Vinci ® robotic surgeons performed resections at a Danish tertiary colorectal high volume center from May 2017 to March 2019. We analyzed the two surgical groups using uni- and multivariate regression analyses to detect differences in intra- and postoperative clinical outcomes and the inflammatory stress response.ResultsTwo hundred and ninety-eight patients were enrolled in the study. Significant differences favoring robot-assisted surgery was demonstrated for; length of hospital stay (4 days, interquartile range (4, 5) versus 5 days, interquartile range (4–7), p < 0.001), and intraoperative blood loss (50 mL, interquartile range (20–100) versus 100 mL, interquartile range (50–150), p < 0.001) compared to laparoscopic surgery. The inflammatory stress response was significantly higher after laparoscopic compared to robot-assisted surgery reflected by an increase in C-reactive protein concentration (exponentiated coefficient = 1.23, 95% confidence interval (1.06–1.46), p = 0.008). No differences between the two groups were found concerning mortality, microradical resection rate, conversion to open surgery, and surgical or medical short-term complication rates.ConclusionRobot-assisted surgery is feasible and can be safely implemented for colorectal resections. The robot-assisted approach, when compared to laparoscopic surgery, was associated with improved intra- and postoperative outcomes. Extensive prospective studies are needed to determine the short- and long-term outcomes of robotic surgery for colorectal cancer.

Highlights

  • Colorectal cancer is a common malignant disease with a global annual incidence of 1.8 million (2017) and an incidence rate of 23.2/100,000 inhabitants [1]

  • Three-hundred and sixty-one patients operated for colorectal cancer were identified, and of these, 298 patients (RCS, n = 143 (48%); Laparoscopic colorectal surgery (LCS), n = 155 (52%)) fulfilled the inclusion criteria (Fig. 1)

  • The present study demonstrates a significant reduction in length of hospital stay, intraoperative blood loss, and inflammatory stress response measured by C-reactive protein (CRP) in patients undergoing colorectal resection for cancer with robot-assisted colorectal surgery (RCS) compared to the LCS

Read more

Summary

Introduction

Colorectal cancer is a common malignant disease with a global annual incidence of 1.8 million (2017) and an incidence rate of 23.2/100,000 inhabitants [1]. Laparoscopic colorectal surgery (LCS) has existed for more than 20 years. The many benefits of LCS compared to open surgery include less postoperative pain, fewer wound complication rates, and improved cosmetic outcomes [2]. The oncological results of LCS and open colorectal surgery are identical, and the 3 to 5-year survival and recurrence rates of the two surgical methods are comparable [2]. Robot-assisted surgery is increasingly implemented for the resection of colorectal cancer, the scientific evidence for adopting this technique is still limited. This study’s main objective was to compare shortterm complication rates, oncological outcomes, and the inflammatory stress response after colorectal resection for cancer performed laparoscopic or robot-assisted

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call